Publications
5600 Results
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 5008); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), oral presentation;
- Year
- 2015
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9346
Long term consequences of intermittent and continuous androgen deprivation in patients with metastatic prostate cancer
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr LBA500); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Cancer Care Delivery
Creating a national collaborative strategy to enhance trial accrual in NCI’s National Clinical Trials Network (NCTN) in the era of precision medicine
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 3531); American Society of Clinical Oncology Annual Meeting (May 29-June 2,2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/N0147
Relationship between metformin use and recurrence and survival in patients (pts) with resected stage III colon cancer (CC) Receiving Adjuvant Chemotherapy: Results from NCCTG N0147 (Alliance).
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 6504); American Society of Clinical Oncology Annual Meeting (May 29-June 2,2015, Chicago, IL), oral;
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: economic analysis of CALGB/SWOG 80405
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 4005); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), oral;
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80701
Randomized phase II study of everolimus alone (E) versus everolimus plus bevacizumab (E+B) in patients with locally advanced or metastatic pancreatic neuroendocrine tumors, CALGB 80701
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr TPS7583); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Lung
- Study Number(s)
- CTSU/E4512
ALCHEMIST: a clinical trial platform to bring genomic discovery and molecularly targeted therapies to early-stage lung cancer
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 533); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Breast
Recurrence score and clinicopathologic characteristics of TAILORx participants by race and ethnicity
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 1007); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), oral;
- Year
- 2015
- Research Committee(s)
- Breast
- Study Number(s)
- CTSU/C40603
Impact of neoadjuvant therapy on breast conservation rates in triple- negative and HER2-positive breast cancer: combined results of CALGB 40603 and 40601 (Alliance)
- Journal / Conference
- Clinical Cancer Research, Apr 1;21(7):1514-1524
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25680375
- PMC
- PMC4654466
- Study Number(s)
- S1400
Lung Master Protocol (Lung-MAP) biomarker-driven protocol for accelerating development of therapies for squamous cell lung cancer: SWOG S1400
- Journal / Conference
- Haematologica Sep;100(9):1214-1221
- Year
- 2015
- Research Committee(s)
- Myeloma
- PMID
- PMID26022710
- PMC
- PMC4800692
- Study Number(s)
- S0120